Published on 18 Apr 2024 on The Business Journals
Sage halts trials in Parkinson’s after drug fails to show benefit - Boston Business Journal
Sage Therapeutics Inc. has decided to halt work on an experimental drugs in Parkinson’s disease...
NASDAQ.SAGE price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free